Across a diverse range of cancer, including melanoma, cardiac hemangioma, glioma, and colorectal cancer, mutations in the POT1 gene have been implicated in the deregulation of telomere maintenance, manifesting as telomere elongation and enhanced telomere fragility [98–101]. Here, POT1 is linked to cancer.